Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease.

Saved in:
Bibliographic Details
Title: Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease.
Authors: Wang, Changyong (AUTHOR), Lv, Shanyu (AUTHOR), Zhao, Hongyan (AUTHOR), He, Guoguo (AUTHOR), Liang, Hongshuo (AUTHOR), Chen, Kemiao (AUTHOR), Qu, Minghai (AUTHOR), He, Yonghua (AUTHOR), Ou, Chaoyan (AUTHOR)
Source: Neurological Sciences. Mar2025, Vol. 46 Issue 3, p1111-1120. 10p.
Subjects: Parkinson's disease, Cerebral anoxia, Medical sciences, Iron metabolism, Iron chelates
Abstract: Background: Parkinson's disease (PD) is a neurodegenerative disease characterized by motor paralysis, tremor,and cognitive impairment. Risk factors such as brain hypoxia caused by aging and abnormal expression of HIF-1α areconsidered to be key to the development of PD, including α-synuclein accumulation and ferroptosis. However, therelationship between HIF-1α signaling and ferroptosis in PD has not been elucidated. The stable expression of HIF-1αinhibits the pathological development of PD. Aging aggravates PD pathology by promoting α-synuclein accumulationand oxidative stress. Methods: The literature on lipid peroxidation, oxidative stress, iron metabolism and other key factors in Parkinson'sdisease in recent years was reviewed through a variety of literature search channels, such as PubMed and Elsevier. Results: HIF-1α mediated ferroptosis through oxidative stress and GPX4-GSH system. HIF-1α mediates ferroptosisthrough Keap1-Nrf2-ARE, Grx3 and Grx4. HIF-1α mediates ferroptosis through iron metabolism. Conclusion: This article reviews the oxygen-dependent regulatory mechanism of HIF-1α and its role in cerebralhypoxia homeostasis. Studies in the past decade have shown that Hif-1α mediated ferroptosis is important in PD.HIF-1α has a dual role, depending on the degree of cellular hypoxia and the environment. The equilibrium complexityneeds to be explained, and the role of ferroptosis needs to be investigated. The literature shows that the stabilizationof HIF-1α with PHD inhibitors and the combination of antioxidants and iron chelators are potential therapeuticdirections. In the future, the optimal use time and dose of inhibitors should be studied to improve the efficacy. [ABSTRACT FROM AUTHOR]
Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 183073177
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wang%2C+Changyong%22">Wang, Changyong</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lv%2C+Shanyu%22">Lv, Shanyu</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhao%2C+Hongyan%22">Zhao, Hongyan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+Guoguo%22">He, Guoguo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liang%2C+Hongshuo%22">Liang, Hongshuo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Kemiao%22">Chen, Kemiao</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Qu%2C+Minghai%22">Qu, Minghai</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22He%2C+Yonghua%22">He, Yonghua</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ou%2C+Chaoyan%22">Ou, Chaoyan</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Mar2025, Vol. 46 Issue 3, p1111-1120. 10p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Parkinson's+disease%22">Parkinson's disease</searchLink><br /><searchLink fieldCode="DE" term="%22Cerebral+anoxia%22">Cerebral anoxia</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+sciences%22">Medical sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Iron+metabolism%22">Iron metabolism</searchLink><br /><searchLink fieldCode="DE" term="%22Iron+chelates%22">Iron chelates</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: Parkinson's disease (PD) is a neurodegenerative disease characterized by motor paralysis, tremor,and cognitive impairment. Risk factors such as brain hypoxia caused by aging and abnormal expression of HIF-1α areconsidered to be key to the development of PD, including α-synuclein accumulation and ferroptosis. However, therelationship between HIF-1α signaling and ferroptosis in PD has not been elucidated. The stable expression of HIF-1αinhibits the pathological development of PD. Aging aggravates PD pathology by promoting α-synuclein accumulationand oxidative stress. Methods: The literature on lipid peroxidation, oxidative stress, iron metabolism and other key factors in Parkinson'sdisease in recent years was reviewed through a variety of literature search channels, such as PubMed and Elsevier. Results: HIF-1α mediated ferroptosis through oxidative stress and GPX4-GSH system. HIF-1α mediates ferroptosisthrough Keap1-Nrf2-ARE, Grx3 and Grx4. HIF-1α mediates ferroptosis through iron metabolism. Conclusion: This article reviews the oxygen-dependent regulatory mechanism of HIF-1α and its role in cerebralhypoxia homeostasis. Studies in the past decade have shown that Hif-1α mediated ferroptosis is important in PD.HIF-1α has a dual role, depending on the degree of cellular hypoxia and the environment. The equilibrium complexityneeds to be explained, and the role of ferroptosis needs to be investigated. The literature shows that the stabilizationof HIF-1α with PHD inhibitors and the combination of antioxidants and iron chelators are potential therapeuticdirections. In the future, the optimal use time and dose of inhibitors should be studied to improve the efficacy. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=183073177
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10072-024-07832-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 1111
    Subjects:
      – SubjectFull: Parkinson's disease
        Type: general
      – SubjectFull: Cerebral anoxia
        Type: general
      – SubjectFull: Medical sciences
        Type: general
      – SubjectFull: Iron metabolism
        Type: general
      – SubjectFull: Iron chelates
        Type: general
    Titles:
      – TitleFull: Hypoxia-inducible factor-1 as targets for neuroprotection : from ferroptosis to Parkinson's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang, Changyong
      – PersonEntity:
          Name:
            NameFull: Lv, Shanyu
      – PersonEntity:
          Name:
            NameFull: Zhao, Hongyan
      – PersonEntity:
          Name:
            NameFull: He, Guoguo
      – PersonEntity:
          Name:
            NameFull: Liang, Hongshuo
      – PersonEntity:
          Name:
            NameFull: Chen, Kemiao
      – PersonEntity:
          Name:
            NameFull: Qu, Minghai
      – PersonEntity:
          Name:
            NameFull: He, Yonghua
      – PersonEntity:
          Name:
            NameFull: Ou, Chaoyan
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 15901874
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Neurological Sciences
              Type: main
ResultId 1